Business
Why Is Plus Therapeutics Stock Gaining Friday?
April 10, 2026
Benzinga
Scroll
Plus Therapeutics stock jumps after FDA grants Orphan Drug status to Reyobiq for pediatric brain cancer, boosting long-term outlook. Importance Rank: 1 read more
Benzinga
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: center